FF-10101-01 is under investigation in clinical trial NCT03194685 (Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California, United States
University Of California, San Francisco School of Medicine, San Francisco, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.